Total planned funding: $218,797,563
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Namibia | $218,797,563 |
Organizational Types
| NGO | $60,130,438 |
| Own Agency | $33,723,380 |
| Host Country Government Agency | $33,496,169 |
| Private Contractor | $28,921,586 |
| Unknown | $26,006,473 |
| University | $22,004,458 |
| Parastatal | $5,044,504 |
| Implementing Agency | $4,722,618 |
| Other USG Agency | $1,961,500 |
| Multi-lateral Agency | $1,626,437 |
| FBO | $1,160,000 |
Program Areas
| Treatment | $55,907,454 |
| Prevention | $46,445,446 |
| Care | $39,854,893 |
| Governance and Systems | $31,592,218 |
| Management and Operations | $26,110,399 |
| Testing | $18,887,153 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $44,794,024 |
| HVMS: Management and Operations | $26,110,399 |
| HVCT: Testing: HIV Testing and Counseling | $18,887,153 |
| HKID: Care: Orphans and Vulnerable Children | $17,710,990 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $15,845,771 |
| OHSS: Health Systems Strengthening | $15,594,633 |
| HBHC: Care: Adult Care and Support | $14,768,562 |
| HVSI: Strategic Information | $12,294,160 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $10,632,504 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $10,051,254 |
| HTXD: Treatment: ARV Drugs | $6,954,349 |
| HMBL: Biomedical Prevention: Blood Safety | $4,630,217 |
| HVTB: Care: TB/HIV | $4,316,487 |
| PDTX: Treatment: Pediatric Treatment | $4,159,081 |
| HLAB: Laboratory Infrastructure | $3,703,425 |
| HMIN: Biomedical Prevention: Injection Safety | $3,232,038 |
| PDCS: Care: Pediatric Care and Support | $3,058,854 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,053,662 |
Top Partner Programs
USG Aggregated Agencies:
$31,404,277
Countries/Regions
Not Available:
$24,712,738
Countries/Regions
Potentia Namibia:
$15,489,199
Countries/Regions